Epidemiological impact of prioritising SARS-CoV-2 vaccination by antibody status: mathematical modelling analyses | BMJ Innovations

Subscribe
Log In More

Log in via Institution
Log in via OpenAthens

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
Basket
Search More

Search for this keyword

Advanced search

Close More
Main menu

Podcasts

Latest content

Current issue

Archive

Authors

About
Subscribe
Log in More

Log in via Institution
Log in via OpenAthens

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
BMJ Journals

Citation Tools

Health technology assessment

Original research

Epidemiological impact of prioritising SARS-CoV-2 vaccination by antibody status: mathematical modelling analyses

Download to a citation manager

Download the citation for this article by clicking on one of the following citation managers:

Cite this article as:: Ayoub HH, Chemaitelly H, Makhoul M, et al

Epidemiological impact of prioritising SARS-CoV-2 vaccination by antibody status: mathematical modelling analyses

BMJ Innovations 2021;7:327-336.